Literature DB >> 26531140

Myopia and diabetic retinopathy: A systematic review and meta-analysis.

Xiang Wang1, Luosheng Tang2, Ling Gao2, Yujia Yang2, Dan Cao2, Yunping Li3.   

Abstract

AIMS: Myopia may have protective effects against diabetic retinopathy (DR). However, the data from epidemiologic studies are inconsistent. We aimed to examine the association between myopia and DR by conducting a meta-analysis.
METHODS: We identified studies by searching the PubMed and EMBASE databases. Study-specific odds ratios (ORs) were pooled using a fixed or random effects model. Myopic eyes were defined as having a spherical equivalent (SE)<-0.5 diopters (D). Myopic SE, each diopter decrease in SE toward myopia, and each millimeter increase in axial length (AL) were used as independent surrogate variables for myopia.
RESULTS: Data from 6 population-based and 3 clinic-based studies were included in the analyses. Myopic SE (compared with emmetropic eyes) and each millimeter increase in AL were associated with a decreased risk for DR (pooled odds ratio [OR], 0.80 and 0.79, respectively; 95% confidence interval [CI], 0.67-0.95 and 0.73-0.86, respectively; P=0.011 and 0.000, respectively). Each millimeter increase in AL was also associated with a decreased risk for vision-threatening diabetic retinopathy (VTDR) (pooled OR, 0.70; 95% CI, 0.60-0.82; P=0.000). No significant association between each diopter decrease in SE and DR was observed.
CONCLUSIONS: Our meta-analysis suggests that individuals with myopia exhibit a decreased risk of developing DR or VTDR. An increased AL plays a critical role in this protective effect.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Association; Axial length; Diabetic retinopathy; Myopia; Odds ratio

Mesh:

Year:  2015        PMID: 26531140     DOI: 10.1016/j.diabres.2015.10.020

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  7 in total

Review 1.  Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.

Authors:  S Priya Narayanan; Esraa Shosha; Chithra D Palani
Journal:  Pharmacol Res       Date:  2019-06-15       Impact factor: 7.658

2.  High myopia is protective against diabetic retinopathy via thinning retinal vein: A report from Fushun Diabetic Retinopathy Cohort Study (FS-DIRECT).

Authors:  Zhong Lin; Dong Li; Gang Zhai; Yu Wang; Liang Wen; Xiao Xia Ding; Feng Hua Wang; Yu Dou; Cong Xie; Yuan Bo Liang
Journal:  Diab Vasc Dis Res       Date:  2020 Jul-Aug       Impact factor: 3.291

3.  Factors protecting against diabetic retinopathy in a geriatric Indian cohort.

Authors:  Jacquelyn N Hamati; Anthony Vipin Das; Gumpili Sai Prashanthi; Umesh C Behera; Raja Narayanan; Padmaja K Rani
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 2.969

4.  Does myopia decrease the risk of diabetic retinopathy in both type-1 and type-2 diabetes mellitus?

Authors:  Swapnil Thakur; Pavan Kumar Verkicharla; Priyanka Kammari; Padmaja Kumari Rani
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

5.  Axial myopia, a protective factor for diabetic retinopathy-role of vascular endothelial growth factor.

Authors:  Ashish Kulshrestha; Nirbhai Singh; Bruttendu Moharana; Parul Chawla Gupta; Jagat Ram; Ramandeep Singh
Journal:  Sci Rep       Date:  2022-05-05       Impact factor: 4.996

6.  Alterations in the Choroidal Sublayers in Relationship to Severity and Progression of Diabetic Retinopathy: A Swept-Source OCT Study.

Authors:  Erica W T Kung; Victor T T Chan; Ziqi Tang; Dawei Yang; Zihan Sun; Yu Meng Wang; C H Chan; Michael C H Kwan; Jian Shi; Carol Y Cheung
Journal:  Ophthalmol Sci       Date:  2022-02-25

7.  Association of Myopia with Peripapillary Retinal Nerve Fiber Layer Thickness in Diabetic Patients Without Diabetic Retinopathy.

Authors:  Hyung Bin Lim; Yong-Il Shin; Min Woo Lee; Jong-Uk Lee; Woo Hyuk Lee; Jung-Yeul Kim
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.